TY - JOUR
T1 - Role of immune status in chemotherapy-induced transient acantholytic dermatosis
AU - Auh, Sogyong L.
AU - Polcari, Ingrid
AU - Petronic-Rosic, Vesna
AU - Sethi, Aisha
N1 - Publisher Copyright:
© 2017 Pulse Marketing & Communications, LLC.
Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2017/11/1
Y1 - 2017/11/1
N2 - A 79-year-old man with a recent diagnosis of acute myeloblastic leukemia received induction chemotherapy with daunorubicin and cytarabine, plus moxifloxacin and fluconazole prophylaxis. Approximately 2 weeks later, an asymptomatic eruption appeared on his trunk. He then developed a neutropenic fever and was started on aztreonam, vancomycin, voriconazole, and amikacin and was transferred to our facility from an outside hospital. Micafungin was subsequently added, and the patient defervesced within a few days.
AB - A 79-year-old man with a recent diagnosis of acute myeloblastic leukemia received induction chemotherapy with daunorubicin and cytarabine, plus moxifloxacin and fluconazole prophylaxis. Approximately 2 weeks later, an asymptomatic eruption appeared on his trunk. He then developed a neutropenic fever and was started on aztreonam, vancomycin, voriconazole, and amikacin and was transferred to our facility from an outside hospital. Micafungin was subsequently added, and the patient defervesced within a few days.
UR - http://www.scopus.com/inward/record.url?scp=85047181110&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85047181110&partnerID=8YFLogxK
M3 - Article
C2 - 29282194
AN - SCOPUS:85047181110
SN - 1540-9740
VL - 15
SP - 483
EP - 484
JO - SKINmed
JF - SKINmed
IS - 6
ER -
